Oxybutynin
Back to searchMolecule Structure
Scientific Name
Oxybutynin
Description of the Drug
Oxybutynin is an antimuscarinic agent that reduces detrusor muscle activity, relaxing the bladder and preventing the urge to void.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01062
http://www.drugbank.ca/drugs/DB01062
Brand Name(s)
Anturol, Contimin 2.5, Contimin 5, Cystrin, Ditropan, Ditropan xl, Kentera, Lyrinel xl, Oxybutynin, Oxytrol, Oxytrol for women, Promictuline, Urimin
Company Owner(s)
Eywa Pharma Inc, Watson Laboratories Inc, Osmotica Pharmaceutical Us Llc, Mylan Pharmaceuticals Inc, Emcure Pharmaceuticals Ltd, Zydus Pharmaceuticals Usa Inc, Allergan Sales Llc, Novitium Pharma Llc, Bionpharma Inc, Tulex Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL211 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2992 | ||||
PharmGKB | PA164746030 | ||||
Human Metabolome Database | HMDB0015195 | ||||
DrugBank | DB01062 | ||||
PubChem: Thomson Pharma | 14778874 | ||||
PubChem | 4634 | ||||
Mcule | MCULE-3407007074 | ||||
LINCS | LSM-5111 | ||||
Nikkaji | J8.038A | ||||
BindingDB | 50165019 | ||||
EPA CompTox Dashboard | DTXSID0023406 | ||||
DrugCentral | 2028 | ||||
Brenda | 16527 | ||||
ChemicalBook | CB42675235 | CB2767266 | CB4587899 | ||
Guide to Pharmacology | 359 | ||||
rxnorm | OXYBUTYNIN CHLORIDE | OXYBUTYNIN | OXYTROL | DITROPAN | GELNIQUE |
KEGG Ligand | C07360 | ||||
ChEBI | 144551 | 7856 |